PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Propoxyphene Hydrochloride W/ Aspirin And Caffeine, and when can generic versions of Propoxyphene Hydrochloride W/ Aspirin And Caffeine launch?
Propoxyphene Hydrochloride W/ Aspirin And Caffeine is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE
US Patents and Regulatory Information for PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE | aspirin; caffeine; propoxyphene hydrochloride | CAPSULE;ORAL | 085732-002 | Sep 3, 1984 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
